Delivery Order SPE2DB22D1017-SPE2DB25FG1MX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pens on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a $14,518.84 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pens on July 15, 2025, with completion scheduled for July 16, 2025. This competitive award carries firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $19,340.01 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound 5 mg/0.5 mL pens valued at $3,050.32 with a completion date of August 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,340.16 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on December 9, 2025, with an ultimate completion date of December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the company's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $45,885.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pens on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $26,070.58 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $30,444.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pens on November 18, 2025, with completion scheduled for November 19, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $18,939.21 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections, with a completion date of January 2, 2026. This is a firm fixed price, non-set-aside contract awarded on December 31, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $2,772.44 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pens on October 28, 2025, with completion targeted for October 29, 2025. This competitively awarded, firm fixed price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 pharmaceutical support vehicle running through...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG1MXDelivery Order
The Defense Logistics Agency awarded a $19,180.80 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pens on April 30, 2025, with completion scheduled for May 1, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. Zepbound, a diabetes and weight management medication, aligns with the company's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains. The delivery order demonstrates the company's ongoing role as a key supplier within the DLA's pharmaceutical support infrastructure, which serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.2k | 4/30/25 |